Aurinia Pharmaceuticals (AUPH) News
NASDAQ: AUPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.70-0.19 (-1.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AUPH news summary
We found 2 recent headlines mentioning Aurinia Pharmaceuticals (AUPH): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, Business Wire. For price context, AUPH is down 1.28% at $14.70. The most recent story, "Aurinia Pharmaceuticals Inc. Q3 Sales Increase", was published by Nasdaq on Oct 30, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Aurinia Pharmaceuticals headlines
- Aurinia Pharmaceuticals Inc. Q3 Sales Increase(RTTNews) - Aurinia Pharmaceuticals Inc. (AUP.V) revealed earnings for third quarter of $31.70 millionNasdaq
- Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business ProgressEDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and nine months ended September 30, 2026 and provided an update on…Business Wire